Skip to main content
Clinical Trials/JPRN-UMIN000052185
JPRN-UMIN000052185
Not yet recruiting
Phase 1

A prospective study on clinical indicators that affect the rate of weight loss in allogeneic hematopoietic stem cell transplantation - Prospective study on weight loss rate in allogeneic hematopoietic stem cell transplantation

Shizuoka Cancer Center0 sites20 target enrollmentSeptember 12, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hematopoietic tumor
Sponsor
Shizuoka Cancer Center
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2023
End Date
March 31, 2027
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Simultaneous active multiple cancers. Case with severe complications. Cases of metastasis to the central nervous system with symptoms. Case of pregnancy or breastfeeding. Case with mental disorder. Cases who answered that they were concerned about the amount of intake recorded on food tags. Cases judged to be inappropriate by the attending physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials